2026. In Silico Design, Molecular Docking, Molecular Dynamics Simulation, and ADMET Evaluation of Novel Quinazoline Derivatives as EGFR Inhibitors for Non-Small-Cell Lung Cancer. Annual Methodological Archive Research Review. 4, 6 (Jun. 2026), 26–71. DOI:https://doi.org/10.5281/zenodo.21820790.